Efficacy of an 8-week course of sofosbuvir and ledipasvir for the treatment of HCV infection in selected HIV-infected patients

Background: With the availability of direct acting antiviral treatment for hepatitis C (HCV), HIV and HCV co-infected patients show comparable treatment responses to HCV-monoinfected patients. An 8-week course of sofosbuvir/ledipasvir (SOF/LDV) is highly effective for the treatment of HCV genotype 1...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:F1000Res
Hlavní autoři: Ogbuagu, Onyema, Hao, Ritche, Virata, Michael, Villanueva, Merceditas S., Malinis, Maricar
Médium: Artigo
Jazyk:Inglês
Vydáno: F1000 Research Limited 2018
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6171717/
https://ncbi.nlm.nih.gov/pubmed/30344999
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.11397.2
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky